✦ LIBER ✦
P-538 Sequential treatment with docetaxel-cisplatin (DP) doublet allows higher conversion to response for patients (pts) with advanced NSCLC in stable disease (SD) after 2 courses of gemcitabine-cisplatin (GP): Preliminary results of a pilot study
✍ Scribed by Moscetti, L.; Nelli, F.; Sperduti, I.; Signorelli, C.; Santiccioli, S.; Saltarelli, R.; Capomolla, E.; Pollena, C.
- Book ID
- 118573442
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 150 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.